Health policies and data

Non-Communicable Diseases (NCD)


OECD work on prevention and control of NCDs in the Americas


OECD and PAHO (Pan American Health Organization) have joined forces to produce the publication “Applying Modeling to Improve Health and Economic Policy Decisions in the Americas: The Case of Noncommunicable Diseases”. The book is the first to exclusively present different economic models and illustrate their application to NCDs in the Region of the Americas. It aims to stimulate the use of economic modeling as a tool to support the decision-making process for NCD interventions, and to encourage investment in cost-effective strategies for healthy living and NCD prevention in the Region. The book introduces several models for assessing health and economic policies in relation to NCDs; shows how the models can be used for different diseases or risk factors; and provides case studies of those models’ application in various countries in the Americas. The ultimate goal is to help policymakers find the best strategies for cost-effective and evidence-based NCD interventions.

> Download the report

This book is one of the outputs deriving from the joint efforts of OECD and PAHO to support countries in the American Region to put in place effective and efficient interventions to tackle key risk factors as unhealthy diet, physical inactivity, obesity, harmful alcohol consumption and tobacco use and associated chronic diseases. The publication of the book “Applying Modeling to Improve Health and Economic Policy Decisions in the Americas: The Case of Noncommunicable Diseases” follows the workshop “Applying Modeling to Improve Health and Economic Policy Decisions in the Americas: The Case of Noncommunicable Diseases” which was held in Mexico City in November 2011.

OECD contribution to the UN High–Level Meeting on the Prevention and Control of Non-communicable Diseases

The World Health Organisation and the Russian Federation have jointly organised the first global ministerial conference on healthy lifestyles and non-communicable disease (NCD) control. The conference took place in Moscow on 28-29 April and was a milestone in the global campaign to fight cancer, cardiovascular disease, diabetes and chronic respiratory disease. The conference was the final step in the run-up to the United Nations’ High–Level Meeting (HLM) on the Prevention and Control of Non-communicable Diseases on 19-20 September 2011.

The OECD played an important role in producing evidence to support the battle against NCDs. It contributed to two background papers for the HLM providing the analytical background on which the final declaration will be based. In particular, the Public Health team contributed to a paper on priorities for investment, providing an assessment of the effectiveness, cost and efficiency of a number of interventions to tackle NCDs and their key underlying risk factors (e.g. tobacco, physical inactivity, etc.). The document reports results of the analyses on healthy diet that OECD and WHO jointly published on the Lancet as part of the third Lancet series on chronic diseases. In addition, new analyses were carried out to assess interventions, specifically designed to increase the level of physical activity in the following WHO regions: EUR-AAMR-B and SEAR-D. The Economics of Prevention team has been also involved in shaping a second paper which discusses indicators and targets that can be used to collect, analyse and disseminate data and information on trends in NCD mortality, disease burden, risk factors and determinants, policies, plans and programmes.

The OECD Economics of Prevention team have also taken part in the Lancet NCD action group, a group of world leading experts on NCDs, and co-authored a position paper that was published in the Lancet on 23rd April. The paper argues that NCD death rates can be reduced by 2% per year by implementing five priority actions, including: i) leadership (continued global and national political commitment); ii) prevention (action on tobacco and other risk factors); iii) treatment (access to affordable essential drugs in primary health care); iv) international cooperation, commitment and funding; and, v) monitoring progress and accountability.‌



For more information, please contact

‌ Small follow us Twitter icon‌ 
Follow us on Twitter @OECD_Social